Request Demo
Last update 07 Feb 2026
Tumour necrosis factor alpha kinoid(Neovacs)
Last update 07 Feb 2026
Overview
Basic Info
Drug Type Therapeutic vaccine |
Synonyms TNF-K, TNFα-kinoid, TNF-K005 |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Tumour necrosis factor alpha kinoid(Neovacs)NCT01911234
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs' TNF-Kinoid in Adult Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT01291810
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety and Immunogenicity of Neovacs' TNFα-Kinoid in Adult Subjects With Crohn's Disease
NCT01040715
A Phase II, Randomized, Double-blind, Controlled Study to Evaluate the Immune Responses, Safety and Clinical Efficacy of Three Doses of Neovacs' TNF-Kinoid in Adult Patients With Rheumatoid Arthritis Who Have Relapsed Despite Anti-TNFα Biological Therapy
100 Clinical Results associated with Tumour necrosis factor alpha kinoid(Neovacs)
Login to view more data
100 Translational Medicine associated with Tumour necrosis factor alpha kinoid(Neovacs)
Login to view more data
100 Patents (Medical) associated with Tumour necrosis factor alpha kinoid(Neovacs)
Login to view more data
100 Deals associated with Tumour necrosis factor alpha kinoid(Neovacs)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rheumatoid Arthritis | Phase 2 | United States | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Belgium | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Hungary | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Lebanon | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Moldova | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | North Macedonia | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Poland | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Russia | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Serbia | 01 Sep 2013 | |
| Rheumatoid Arthritis | Phase 2 | Ukraine | 01 Sep 2013 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | TNF alpha | 40 | TNF-Kinoid 90 mcg | xejloktier(xgllfopvuh) = jvczbenmeg dijethxnmm (jnhtenheid ) View more | - | 06 Jun 2012 | |
Placebo | xejloktier(xgllfopvuh) = jnhnptaaoh dijethxnmm (jnhtenheid ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free